Effectiveness of Standard Therapy of Acne Vulgaris
- Disease/Condition
- Acne Vulgaris
- Study type
- Observational
- Primary sponsor
- Indonesia University
- Location
- Jakarta Pusat, Indonesia
- Phase
- N/A
- Start date
- Apr 18, 2023
- End date
- Jun 05, 2023
- Enrollment
- 724 participants
Change in non-inflammatory acne lesion count,Change in inflammatory acne lesion count,Change in total acne lesioncount,Change in acne severity
This study was to evaluate the effectiveness of standard therapy for acne vulgaris (AV) based
 on the clinical practice guidelines (CPG) in Indonesia. The main questions it aims to answer
 were:
 
 1. How is the clinical characteristics of patients with AV in dr.Cipto Mangunkusumo
 Hospital?
 
 2. How is the effectiveness of standard therapy for AV based on the CPG in Indonesia in
 reducing the number of non-inflammatory, inflammatory, and total lesions and degree of
 acne severity?
 
 The clinical pratice guideline (CPG) used for analysis was CPG by dr.Cipto Mangunkusumo
 Hospital 2017 in line with the date of patient visit. Data of 724 patients with AV in
 dr.Cipto Mangunkusumo Hospital as recorded in the medical records were assessed for
 eligibility. Data of 3-month-follow-up data of included subjects were collected and analyzed.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05982613
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05982613 through Pure Global AI's free database. This phase not specified trial is sponsored by Indonesia University and is currently Completed. The study focuses on Acne Vulgaris. Target enrollment is 724 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.